Ülke: İspanya
Dil: İngilizce
Kaynak: HMA (Heads of Medicines Agencies)
flunixin 50 mg/ml
Norbrook Laboratories Limited
QM01AG90
Solution for injection
flunixin
Pigs Food
2008-07-16
Dokument1 PACKAGE LEAFLET FOR: NORFLUNIX 50 MG/ML SOLUTION FOR INJECTION FOR PIGS 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder and manufacturer responsible for batch release: Norbrook Laboratories Limited Station Works Camlough Road Newry, Co. Down BT35 6JP Northern Ireland 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Norflunix 50 mg/ml solution for injection for pigs Flunixin meglumine 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS Each ml contains: ACTIVE SUBSTANCE: Flunixin 50 mg (equivalent to Flunixin meglumine 82.9 mg) EXCIPIENTS: Phenol 5 mg Sodium formaldehyde sulphoxylate dihydrate 2.5 mg Flunixin meglumine is a relatively potent non-narcotic and non-steroidal analgesic with anti- inflammatory and anti-pyretic properties. 4. INDICATION(S) For alleviation of Mastitis-Metritis-Agalactia Syndrome (MMA) with appropriate antibiotic treatment to reduce clinical signs. 5. CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of excipients. Do not use in animals suffering from hepatic, renal, or cardiac disease. Do not use in animals with lesions of the gastrointestinal tract (for example gastro intestinal ulceration or bleeding). Do not use when there is evidence of blood dyscrasia. Do not use in dehydrated, hypovolaemic or hypotensive animals. 6. ADVERSE REACTIONS Dokument1 Flunixin meglumine is a non steroidal anti-inflammatory drug (NSAID). Untoward effects include gastrointestinal irritation, ulceration and, esp Belgenin tamamını okuyun
SPC Norflunix 50 mg/ml solution for injection for pigs_Day 90 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Norflunix 50 mg/ml solution for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Flunixin 50 mg (equivalent to Flunixin meglumine 82.9 mg) EXCIPIENTS: Phenol 5 mg Sodium formaldehyde sulphoxylate dihydrate 2.5 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. A clear colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For alleviation of Mastitis-Metritis-Agalactia Syndrome (MMA) with appropriate antibiotic treatment to reduce clinical signs. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of excipients. Do not use in animals suffering from hepatic, renal, or cardiac disease. Do not use in animals with lesions of the gastrointestinal tract (for example gastro- intestinal ulceration or bleeding). Do not use when there is evidence of blood dyscrasia. Do not use in dehydrated, hypovolaemic or hypotensive animals. SPC Norflunix 50 mg/ml solution for injection for pigs_Day 90 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The cause of the underlying inflammatory condition should be determined and treated with appropriate concomitant therapy. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use of the product in the immediate postpartum period may interfere uterine invo Belgenin tamamını okuyun